Visit the WIS FDA Info.com for the best regulatory news and information

Many of our recently held briefings are available on audiocassette files. Visit our Tapes Library for our highly regarded series on:

  21 CFR Part 11
  Adverse Event
Reporting
  Branded/Generic
Drug Policy
  Clinical Research
  Computer Validation 
  FDA Enforcement
  Human Research Protections
  Prescription Drug Marketing
  Order Form


Tapes Library

21 CFR Part 11: Electronic Records & cGMP Initiative
Speaker:
Robert W. Stotz, Ph.D., Validation Technologies
Date of Briefing:
October 16, 2003
Approximate length:
One hour
Description:
According to FDA, the withdrawal was precipitated by its new initiative (announced August 21, 2002) to enhance FDA’s current good manufacturing practice program to focus regulatory attention on those aspects of manufacturing that pose the greatest risk, ensure that FDA’s work does not impede innovation, and enhance the consistency of FDA’s regulatory approach. Robert W. Stotz, Ph.D. of Validation Technologies, Inc will provide an exclusive update on both of these developments.
Price:
$195 Tape
ttttttttttttt
Go to the Order Form

Tapes Library

21 CFR Part 11: Risk-Based Plans for Part-11 Compliance
Speaker:
Robert W. Stotz, Ph.D., Validation Technologies
Date of Briefing:
June 17 , 2003
Approximate length:
One hour
Description:
After hearing Dr. Stotz’ briefing, you will learn: how to assess the impact of FDA’s “full circle” approach on enforcement activities; what elements of Part 11 are affected by enforcement discretion; which systems implemented prior to the effective date of Part 11 still have to comply; how these developments will change the validation of computer systems; and how to implement a risk-based approach to Part 11 compliance.
Price:
$195 Tape

Go to the Order Form

Click here to visit Expert Briefings from 2002.



 

Page last updated October 16, 2006

Washington Information Source © Copyright 2006

208 South King Street, Leesburg, VA 20175
Tel: (703) 779-8777 . Fax: (703) 779-2508
service@fdainfo.com
. www.fdainfo.com/expertbriefings/

This site has been accessed: times since April 7, 2003